GlassScriptPhysician profile
Richard Cline
NPI 1245237080
$779.99
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $42.88 · 2021: $306 · 2022: $153 · 2023: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.39 · Education: $24.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.39 |
| Education | $24.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $120.58 | 2021-2023 | Farxiga |
| Fresenius USA Marketing, INC. | $117.65 | 2019 | |
| Amgen INC. | $81.88 | 2019-2022 | |
| Boston Scientific Corporation | $76.82 | 2021-2022 | |
| Abbvie INC. | $69.80 | 2021 | |
| Glaxosmithkline, LLC. | $44.57 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $43.14 | 2021-2023 | Jynarque |
| Allergan, INC. | $42.23 | 2019-2020 | |
| Lilly USA, LLC | $29.24 | 2021 | |
| Opko Pharmaceuticals, LLC | $24.85 | 2023 | Rayaldee |
| Travere Therapeutics, INC. | $22.84 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.26 | 2021 | |
| Vifor Pharma, INC. | $16.78 | 2023 | Veltassa |
| Therapeuticsmd, INC. | $15.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.12 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $14.85 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $11.80 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Cline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.